Study of a new medicine in healthy men with normal or overweight
This study tests how a new medicine (BI 3034701) moves through the body in healthy men who have normal weight or are overweight. It helps find the right dose and understand how the medicine works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy man between 18 and 65 years old.
- Your body mass index (BMI) is between 23.0 and 34.9.
- You have no major health problems like high blood pressure, heart issues, or abnormal lab results.
- You are willing to sign a consent form to join the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine (BI 3776528) in healthy men to see how well different doses are tolerated. It helps researchers find the safest dose before testing in people with a condition.
This trial tests different doses of a new medicine in healthy Japanese people and those with obesity or overweight. It aims to see how well the body handles the drug and if it is safe.
This trial tests how safe and tolerable different doses of the study drug BI 3814916 are in healthy adults. It helps find the right dose for future studies.
This study tests how a new medicine, BI 3000202, is absorbed into the blood. It includes people with different levels of liver function (normal, mild, moderate, or severe) to see if liver problems affect how the medicine works.
This trial tests a new medicine called BCD-261 in healthy men to see if it is safe and how the body processes it. Participants will receive increasing doses and be monitored for about 4 months.
This study tests how a drug called BI 3002022 interacts with certain transport proteins in healthy men. It may help researchers understand how the drug is absorbed and eliminated by the body.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.